Hong Kong Stock Announcement Highlights | China Jinmao Reports Contracted Sales of RMB 31.234 Billion for First Four Months, Up 23.44% Year-on-Year

Stock News05-12

Significant Developments: CGN Power (01816): Huizhou Unit 4 Commences Full-Scale Construction. Bioheart-B (02185): IBERIS® RDN System Registered in Vietnam. Lopal Tech (02465): Changzhou Lithium Source Secures RMB 440 Million in Series B Funding to Boost LFP Capacity. Shanghai Fudan Microelectronics (01385) Plans Joint Establishment of Integrated Circuit Technology Center with Fudan University. China Traditional Chinese Medicine (00570): Class 3.1 Ancient Classical Formula TCM Preparations—Shaoyao Gancao Decoction Granules and Taobe Chengqi Decoction Granules Approved for Market Launch. CSPC Pharmaceutical (01093): SYS 6010 Included Again in China's Breakthrough Therapy List for Treatment of Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma. Ribobio-B (06938): Core Product VORTOSIRAN Completes Submission of Phase 2b Clinical Trial Application for Venous Thromboembolism Indication. Baiyunshan (00874): Tianxin Pharmaceutical Receives "Drug Supplementary Application Approval Notice" for Cefuroxime Sodium for Injection 0.5g and Candesartan Cilexetil Tablets 4mg. Fuso Pharmaceutical (01652): Lornoxicam for Injection Approved for Market Launch. CanSino Biologics (06185): NDA for Td5cp for Adolescents and Adults Included in Priority Review by China's NMPA Center for Drug Evaluation. Shandong Xinhua Pharmaceutical (00719) Obtains Drug Registration Certificate for Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution.

Operating Performance: FIT HON TENG (06088) Reports Q1 Revenue and Other Operating Income of USD 1.198 Billion, Up 8.61% Year-on-Year. Pou Sheng International (03813) Posts April Consolidated Net Operating Revenue of Approximately RMB 1.376 Billion, Up 0.1% Year-on-Year. Yue Yuen Industrial (00551) Reports April Consolidated Net Operating Revenue of Approximately USD 702 Million, Up 6.69% Year-on-Year. China Jinmao (00817) Achieves Cumulative Contracted Sales of RMB 31.234 Billion for the First Four Months, a 23.44% Increase Year-on-Year. Boyaa Interactive (00434) Anticipates Q1 Adjusted Profit Attributable to Owners to Rise Approximately 85% to 90% Year-on-Year. Tuya Smart-W (02391) Reports Q1 Net Profit of USD 15.8 Million, Up 43.2% Year-on-Year, with AI Business Revenue Growing 16.9% as a New Engine.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment